Stay updated on AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedA new Revision: v3.5.4 was added to the Study Record Versions. The previous Revision: v3.5.3 was removed from the list.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Record History shows a new latest revision of v3.5.3, replacing v3.5.2, indicating the study record has been updated.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the version history.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.2%

- Check60 days agoChange DetectedRecord History shows multiple version updates to the study record, including changes to Recruitment Status, Study Design, Outcome Measures, and Contacts/Locations, with a 'Quality Control Review Has Not Concluded' notice.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision v3.4.3 was added and v3.4.2 removed from the history, indicating a minor update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.